Skip to main content
Main navigation
Rapid Reactions
Schizophrenia Foundations
Symptomatology
Patient Burden
Caregiver Perspectives
Psychopharmacology
Search
Main navigation
Rapid Reactions
Schizophrenia Foundations
Symptomatology
Patient Burden
Caregiver Perspectives
Psychopharmacology
Search
Psychopharmacology
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?
What’s the Role of Amantadine in Anticholinergic Deprescription?
CME: The Future of Schizophrenia Care: A Closer Look at the Role of Muscarinic Acetylcholine Receptor Activation
CME: Emerging Therapeutic Targets for Schizophrenia: A Focus on Muscarinic Acetylcholine Receptor Activation
Navigating the A to Z of Schizophrenia, Part 3: Novel Treatment Mechanisms
Great Debates: Exploring Muscarinic Agonists in Schizophrenia Treatment
Muscarinic Pathways in Schizophrenia: Unlocking New Therapeutic Targets
CME: Meet Me at the Water Cooler: Schizophrenia
End of the Anticholinergic Era? Challenging Cases in Anticholinergic Deprescribing: Real-World Scenarios (Module 4)
End of the Anticholinergic Era? Deprescribing with Confidence: Strategies for Safe Medication Changes (Module 3)
End of the Anticholinergic Era? Measuring the Impact: Understanding Anticholinergic Burden (Module 2)
Pagination
First page
« First
Previous page
‹ Previous
Page
1
Page
2
Current page
3
Page
4
Page
5
Next page
Next ›
Last page
Last »